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Background: Aerosol generating medical procedures (AGMPs) are common during
newborn resuscitation. Neonates with respiratory viruses such as severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection may pose a risk to
healthcare workers. International guidelines differ on methods to minimize the risk
due to limited data.
Objective: We examined the expiratory airflow dispersion during common neonatal
resuscitation AGMPs using infant simulators.
Methods: Expiratory airflow dispersion in term and preterm manikins was simulated
(n = 288) using fine particle smoke at tidal volumes of 5ml/kg. Using ImageJ, we
quantified dispersion during common airway procedures including endotracheal
tube (ETT) and T‐piece ventilation.
Results: Maximal expiratory dispersion distances for the unsupported airway and
disconnected uncuffed ETT scenarios were 30.2 and 22.7 cm (term); 22.1 and
17.2 cm (preterm), respectively. Applying T‐piece positive end expiratory pressure
(PEEP) via an ETT (ETTPEEP) generated no expiratory dispersion but increased tube
leak during term simulation, while ventilation breaths (ETTVENT) caused significant
expiratory dispersion and leak. There was no measurable dispersion during face
mask ventilation. For term uncuffed ETT ventilation, the particle filter eliminated
expiratory dispersion but increased leak. No expiratory dispersion and negligible
leak were observed when combining a cuffed ETT and filter. Angulated T‐pieces
generated the greatest median dispersion distances of 35.8 cm (ETTPEEP) and
23.3 cm (ETTVENT).
Conclusions: Airflow dispersion during neonatal AGMPs is greater than previously
postulated and potentially could contaminate healthcare providers during re-
suscitation of infants infected with contagious viruses such as SARS‐CoV‐2. It is
possible to mitigate this risk using particle filters and cuffed ETTs. Applicability in
the clinical setting requires further evaluation.
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1 | INTRODUCTION
Highly infectious respiratory viruses are associated with sig-
nificant morbidity and mortality including severe acute re-
spiratory syndrome coronavirus 2 (SARS‐CoV‐2) coronavirus
disease 2019 (COVID‐19).1 Healthcare workers (HCWs) exposed
to aerosol generating medical procedures (AGMPs) are vulner-
able to respiratory virus contamination,2 particularly if appro-
priate personal protection equipment (PPE) is unavailable, such
as in low‐resource settings, or is incorrectly used. Furthermore,
respiratory bioaerosols from infected patients can contaminate
the environment posing additional risk to other patients, visitors,
and HCWs not immediately caring for the patient.3
Neonatal airway maneuvers are AGMPs and common during
resuscitation in delivery rooms.4 Although full PPE is re-
commended when resuscitating newborn infants where maternal
COVID‐19 is suspected or confirmed, international guidelines
assessed the SARS‐CoV‐2 contamination risk to HCWs to be
low5,6 as the vertical transmission is unlikely.7,8 However, the UK
Obstetric Surveillance System (UKOSS) study9 found that 5% of
babies born to SARS‐CoV‐2 positive mothers had positive SARS‐
CoV‐2 tests. As only symptomatic patients were tested, many
more could have asymptomatic SARS‐CoV‐2 infection.10 More
recent U.K. data11 found the incidence of SARS‐CoV‐2 positive
infants ≤28 days old requiring hospital treatment during the first
pandemic wave was 5.6 per 10 000 births, with a quarter born to
positive mothers, a quarter born preterm, and many in neonatal
and pediatric intensive care units. Furthermore, 42% of positive
neonates were classified as having severe neonatal SARS‐CoV‐2
infection and 33% required respiratory support including in-
vasive ventilation.
The effects of maternal COVID‐19 around the time of birth
and the associated higher preterm birth rate9 could increase the
need for HCWs to attend deliveries and provide resuscitation or
stabilization and on‐going care. Furthermore, infants may need
readmission to hospital with community‐acquired infection and
require airway support in emergency departments, pediatric
wards, and intensive care units. Providing care in these settings
could expose HCWs to SARS‐CoV‐2, especially during AGMPs.
There is insufficient evidence behind the airflow dispersion pat-
tern and transmission risk to HCWs when performing AGMPs
during neonatal resuscitation or stabilization.12,13
It is postulated that aerosolization during AGMPs in neonatal
resuscitation is much lower than that of an adult due to the lower
tidal volumes with dispersion distances of <2 cm estimated.6,12
However, there are no neonatal data to support this and it is
difficult to extrapolate the limited adult data14 into neonatal
settings. This has resulted in uncertainty and differences within
international recommendations to minimize the contamination
risk during neonatal AGMPs.5,6,15–17 We aimed to examine the
expiratory air dispersion during common neonatal AGMPs using
term and preterm infant simulators and methods to reduce
dispersion.
2 | MATERIALS AND METHODS
This simulation study used both term and preterm scenarios. All
experiments were conducted in the Trent Simulation and Skills
Centre (Nottingham University Hospitals NHS Trust, Nottingham,
UK). The room used was identical to a typical obstetric theater used
for surgical delivery of newborn infants with a resuscitaire (Hill‐Rom
Air‐Shields RW82 VHA‐1C) placed against the wall >2m from the
mother. This facility does not use negative pressure ventilation.
Ethical approval is not required as this is a simulation study using
manikins.
2.1 | Simulation model
Neonates create relatively small volumes during respiration. We used
tidal volumes of 5ml/kg for each simulation as this fell within the typical
4–6ml/kg domains recommended by Keszler.18 Simulations were re-
created with term (Laerdal, Norway) and preterm infant manikins
(Laerdal Premature), using a tidal volume of 15 and 5ml per breath,
respectively, based on a 3 kg term and 1 kg preterm newborn. The right
bronchus of the manikin was clamped off to re‐create a full expiration.
A three‐way tap with sealed tubing was attached to the left bronchus to
instill smoke to visualize expiratory airflow pathways.
For each experiment, the same investigator (T.C.K.) injected the
desired tidal volume over 0.5 s. The first breath was used to prime
the dead space and was not included in the analysis, with subsequent
breaths used for quantification. Four breaths were instilled on three
different occasions giving nine quantifiable dispersion measures for
each scenario.
2.2 | Airflow dispersion visualization
Previous studies have used fluid‐based smoke generators to recreate
aerosol dispersion data producing small particles <1 μm diameter,
which poses the greatest bioaerosol risk as they linger longer in the
air and penetrate deeper into the respiratory system.3,19,20 A 500W
smoke machine (HA0196R; AGPtEK) was used to create nontoxic
smoke with a mixture of mineral oil and glycol high‐grade medium
density fluid (160.587 UN; AVSL). To visualize the smoke, the room
was fully darkened, and a black polyester background was used to
negate any visual interference. Particle illumination was achieved
using a 10 000 Lux LED light panel (Nature Bright). Video images
were captured on a GoPro Hero high definition camera (12mega-
pixels 1080 at 25 frames/s; GoPro) fixed to a stand and placed 75 cm
away from the manikin's mouth (E‐video 1a‐n).
2.3 | Experimental procedures
Common AGMPs occurring during newborn airway maneuvers in
neonatal resuscitation in the delivery room or intensive care4 were
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TABLE 1 Table depicting the median
(interquartile range) expiratory dispersion
and leak, as well as maximum dispersion
distance for the common aerosol
generating medical procedures occurring
during newborn airway maneuvers
Scenario Model
Expiratory







































































ETTSIB + Filter Term 0 11.7 (10.4–22.6) 27.0
Cuffed ETT Term 19.0 (16.2–19.8) 0 22.3
Cuffed ETTPEEP Term 22.7 (20.8–23.3) 0 (0–0.9) 23.9
Cuffed ETTPEEP + Filter Term 0 3.3 (0–4.3) 4.6
Cuffed ETTPEEP + Angled Term 35.8 (31.1–36.7) 0 37.5
Cuffed
ETTPEEP + Angled + Filter
Term 0 3.0 (0–3.7) 3.8
Cuffed ETTVENT Term 19.2 (17.9–20.3) 0 (0–3.0) 21.0
Cuffed ETTVENT + Filter Term 0 5.1 (3.1–6.6) 8.5
Cuffed ETTVENT + Angled Term 23.3 (22.1–27.4) 0 30.0
Cuffed
ETTVENT + Angled + Filter
Term 0 4.0 (1.0–5.8) 11.1
Cuffed ETTSIB Term 6.7 (5.7–9.7) 0 10.8
Cuffed ETTSIB + Filter Term 0 0 (0–4.3) 4.3
Note: N = 9 exhalations per method.
Abbreviations: angled, angulated T‐piece; ETT, endotracheal tube; PEEP, standard T‐piece positive
end expiratory pressure; SIB, self‐inflating bag ventilation breath; VENT, standard T‐piece ventilation
breath.
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assessed. Airway procedures included: (1) unsupported airway; (2)
standard uncuffed endotracheal tube (ETT) (3.0 mm diameter pre-
term, 3.5 mm diameter term; Portex Blue Line; Smiths Medical); (3)
3.5 mm cuffed ETT (Parker Medical; P3 Medical); (4) self‐inflating bag
(SIB; Laerdal Silicone Resuscitator); (5) silicone face mask (term and
preterm; NeoFlow resuscitation masks; Armstrong Medical); (6)
standard and angulated T‐piece (Fisher & Paykel Healthcare); and (7)
a particle filter (dead space approximately 35ml; Ultipor 25). The
airway procedures were carried out by D.S., an experienced neonatal
consultant.
The study aims were to explore ways to minimize the aerosol
dispersion around infants, thereby limiting the potential exposure
risk of HCWs to highly infectious respiratory viruses including
SARS‐CoV‐2. Therefore, we assessed three approaches to minimize
aerosol dispersion: (1) particle filter; (2) cuffed ETT; and (3) angu-
lated T‐piece (allowing airflow to be directed toward the feet rather
than vertically).
2.4 | Airflow dispersion quantification
For each quantifiable breath, we identified the maximal dispersion
point and captured the freeze‐frame image. These images were
loaded into ImageJ analysis software.21 Two researchers (T.C.K. and
R.S.) independently measured the dispersion distances using ImageJ.
A 5 cm marker placed at the manikin's head was used by ImageJ to
scale each experiment when calculating dispersion distance. For the
dispersion and leak measurement in the unsupported airway sce-
narios, the measurement point was from the tip of the manikin's
nose. Airway leak was measured from the manikin's nose/mouth
when using airway adjuncts. For ETT, T‐piece, and SIB the mea-
surement point was from the airflow outlet of each device
(E‐image 1). Experiments with an ETT were conducted using a
T‐piece at 8 L/min flow rate with 5 cm H2O positive end expiratory
pressure (PEEP) (ETTPEEP), T‐piece with ventilation breaths
(ETTVENT) of 30 cm H2O (term), and 25 cm H2O (preterm),
4 or a SIB
with manual ventilation breaths (ETTSIB). Data for each experiment
were averaged and any significant outliers (>10% difference between
two researchers) were adjudicated by a third researcher (D.S.).
2.5 | Statistical analysis
Data were not normally distributed, so dispersion distance was
presented as median and inter‐quartile range (IQR) along with
maximum range to highlight the potential dispersion range. Mea-
sures of dispersion, and approaches to minimize these, were com-
pared using Mann–Whitney U test with p < .05 considered
significant. Data were analyzed using GraphPad Prism (Prism v8).
3 | RESULTS
A total of 23 scenarios were performed with nine dispersion mea-
surements quantified per scenario giving 288 measurements in total.
3.1 | Unsupported airway and face mask
ventilation
In the unsupported airway scenario, the median expiratory disper-
sion distances were 21.4 cm (term) and 11.3 cm (preterm) with
maximal distances of 30.2 cm (term) and 22.1 cm (preterm). There
was no measurable expiratory dispersion or leak during face mask
ventilation using a standard T‐piece. A median expiratory dispersion
F IGURE 1 Representative images of airway dispersion pattern
from term and preterm manikins in the unsupported airway scenario
with bar chart representing dispersion distances. Grids represent
5 cm × 5 cm area. N = 9 per simulation [Color figure can be viewed at
wileyonlinelibrary.com]
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distance of 2.2 cm was generated with face mask ventilation for the
preterm manikin using a SIB (Table 1 and Figure 1).
3.2 | ETT
Using a disconnected, uncuffed, and uncut ETT, the median disper-
sion distances were 11.3 cm (term) and 12.0 cm (preterm). Ventila-
tion using an ETTSIB produced median dispersion distances of
19.5 cm (term) and 4.8 cm (preterm) (Table 1 and Figure 2).
Applying PEEP via a T‐piece (ETTPEEP) resulted in no visible
expiratory dispersion but increased leak during term simulation with
median leak distance of 10.3 cm, while ventilation breaths (ETTVENT)
caused significant expiratory dispersion (median of 19.0 cm) and leak
(median of 11.8 cm). In the preterm simulation, the median
dispersion distance during ETTPEEP and ETTVENT were 16.5 and
13.4 cm, respectively. No leak was visible across all preterm simu-
lations using a 3.0 mm diameter ETT (Table 1 and Figure 2).
3.3 | Methods to minimize expiratory dispersion
from neonatal AGMPs
3.3.1 | Particle filter
For term uncuffed ETT, the particle filter reduced expiratory dis-
persion distances to zero although at the expense of increased leak.
The median leak distances when particle filter was added onto term
uncuffed ETT were 5.9 cm (ETT disconnected), 8.6 cm (ETTVENT), and
11.7 cm (ETTSIB), respectively (Table 1 and Figure 3).
F IGURE 2 Representative images from
term and preterm manikin airflow dispersion
in the uncuffed endotracheal tube (ETT)
scenarios (ETT disconnected, standard T‐piece
peak end expiratory pressure (ETTPEEP),
standard T‐piece ventilation breaths
(ETTVENT), and self‐inflating bag ventilation
breaths (ETTSIB)) with bar chart representing
dispersion distances and any measurable leak.
Grids represent 5 cm × 5 cm area. N = 9 per
simulation [Color figure can be viewed at
wileyonlinelibrary.com]
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3.3.2 | Cuffed ETT
Combining the cuffed ETT and particle filter reduced
expiratory dispersion across all scenarios to a negligible
amount. However, this was associated with a significant
increase in the leak although this was less than that of
the uncuffed ETT. The median leak was 3.3 cm (ETTPEEP),
5.1 cm (ETTVENT), and 0 cm (ETTSIB), respectively (Table 1 and
Figure 4).
3.3.3 | Angulated T‐piece
Using a cuffed ETT with an angulated T‐piece, the expiratory airflow
dispersion was directed away from the operator. However, this re-
sulted in a significant increase in dispersion distance for both
ETTPEEP (median 35.8 cm vs. 22.7 cm, p < 0.01) and ETTVENT (median
23.3 cm vs. 19.2 cm, p < 0.01) compared to the standard T‐piece.
Inclusion of the filter eliminated all measurable expiratory dispersion
with a small increase in the leak (Table 1 and Figure 5).
F IGURE 3 Representative images from
term manikin airflow dispersion with the
addition of a particle filter in the uncuffed
endotracheal tube (ETT) scenarios (ETT
disconnected, standard T‐piece ventilation
breaths (ETTVENT) and self‐inflating bag
ventilation breaths (ETTSIB)), with bar chart
representing dispersion distances and any
measurable leak. Grids represent 5 cm × 5 cm
area. N = 9 per simulation, *p < .05, and
**p < .01 [Color figure can be viewed at
wileyonlinelibrary.com]
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4 | DISCUSSION
Airflow dispersion during AGMPs in neonates has not previously
been reported but is of significant importance to HCWs caring
for infants infected with highly contagious respiratory viruses
such as SARS‐CoV‐2. We demonstrate that even at small tidal
volumes, significant airflow dispersion occurs during common
neonatal AGMPs in newborn resuscitation. The expiratory dis-
persion for some of the common neonatal AGMPs may be over 10
times the distance previously postulated,12 exceeding many in-
cubator or resuscitaire platform footprints. This poses a con-
tamination risk to those undertaking newborn AGMPs in infants
with SARS‐CoV‐2, albeit a low risk. HCWs need to carry out
newborn resuscitation in close proximity to the airway due to the
small size of the infant and the intricacies of the procedures,
making contamination more likely. Furthermore, resuscitation of
newborn infants in intensive care settings often occurs in an in-
cubator or on a resuscitaire whereby a negative pressure en-
vironment is not standard or possible, potentially increasing the
exposure risk to airborne particles.22–24
4.1 | Face mask ventilation
Face mask ventilation is one of the most common methods used
to support newborn breathing. We found no measurable
F IGURE 4 Representative images from
term manikin airflow dispersion using a cuffed
ETT in addition to the particle filter across
various scenarios (standard T‐piece peak end
expiratory pressure (ETTPEEP), standard
T‐piece ventilation breaths (ETTVENT), and
self‐inflating bag ventilation breaths (ETTSIB)),
with bar chart representing dispersion
distances and any measurable leak. Grids
represent 5 cm × 5 cm area. N = 9 per
simulation, *p < .05, and **p < .01 [Color figure
can be viewed at wileyonlinelibrary.com]
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dispersion or leak during face mask ventilation. This is
potentially due to the greater dead space within the
oropharynx25 and the face mask itself (preterm 25 ml and term
35 ml). Although we did not explore the impact of practitioner's
experience on airflow dispersion, good mask technique is crucial
during face mask ventilation to minimize dispersion of expired
air. The use of a particle filter during face mask ventilation may
increase the leak due to the extra weight of the filter, especially
in the hands of practitioners with limited neonatal resuscitation
experience.
4.2 | Particle filter
Particle filters, as used in this study, are reported to remove almost
100% of airborne and liquid‐borne pathogens including viruses.26 In
our study, the particle filter almost eliminated the expiratory airflow
dispersion, potentially reducing the risk of viral dispersion. This is
consistent with findings in adult practice.19,27 However, the neonatal
simulation models revealed that the elimination of expiratory dis-
persion with particle filters occurs at the expense of increased leak
from an uncuffed ETT. Furthermore, the filter may add dead space
and increase system resistance to the ventilatory circuit. Hence, it is
advisable to use the appropriate size filter for newborn infants and
avoid prolonged ventilation using this approach, especially in the
smaller, extremely preterm infants.12,13 It is also unclear if the ad-
dition of a filter could affect ventilatory technique especially during
mask ventilation. The extra weight of the filter may impair effective
mask ventilation technique leading to increased leak. We did not
observe any visible leak although this requires further evaluation
using respiratory monitors, which are able to measure leak.
4.3 | Cuffed or tight‐fitting endotracheal tube
The combination of a particle filter with cuffed or tightly fitting ETT
eliminated expiratory dispersion and reduced the leak compared to
an uncuffed ETT. However, in neonates, the use of cuffed or tight‐
fitting ETTs can increase the risk of airway trauma and edema, al-
though newer tubes may be safer for short‐term ventilation.28
Hence, cuffed or tight‐fitting ETTs should be used with caution,
especially for a prolonged period and in extremely preterm infants. If
cuffed ETTs are used, a one‐half to one size internal diameter smaller
than that of uncuffed ETTs should be used.
4.4 | Angulated T‐piece
The angulated T‐piece resulted in the greatest expiratory dispersion
when compared to the standard T‐piece. This is likely due to the
direction of gas flow and reduced airflow resistance in the angulated
structure. Although the expired dispersion is directed away from the
healthcare professional performing the airway maneuver, the greater
expiratory dispersion distance increases the contamination risk of
other healthcare providers who are within close proximity to the
infant.
4.5 | Strengths
To the best of our knowledge, our study provides the first neonatal
expiratory airflow dispersion data during common neonatal re-
suscitation AGMPs using term and preterm infant simulators. This
provides new data to guide recommendations during newborn re-
suscitation and support mitigation strategies for HCWs resuscitating
F IGURE 5 Representative images of airway dispersion pattern
from term manikins using a cuffed endotracheal tube (ETT) in
addition to (a) angulated T‐piece; (b) standard T‐piece; (c) angulated
T‐piece with filter; and (d) standard T‐piece with filter, with bar chart
representing dispersion distances and any measurable leak. Grids
represent 5 cm × 5 cm area. N = 9 per simulation and **p < .01.
ETTPEEP, endotracheal tube with T‐piece peak end expiratory
pressure, ETTVENT, endotracheal tube with T‐piece ventilation breath
[Color figure can be viewed at wileyonlinelibrary.com]
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infants with, or at risk of, contagious respiratory viral infections such
as SARS‐CoV‐2.
4.6 | Limitations
As this is a simulation study, applicability in the clinical setting, en-
vironmental factors such as room airflow and filter dead space need
further evaluation. Negative pressure rooms are often used for
caring for patients with infectious respiratory disease, but these are
often not available in the neonatal setting. Hence, additional ex-
amination in these settings would be desirable. There are no suitable
neonatal manikins able to recreate different lung pathologies. Hence,
we focused on the expiratory phase of respiration when AGMPs are
most likely to create the greatest aerosol and risk of contamination.
Airflow dispersion will vary depending on underlying clinical char-
acteristics and pathology.
The airflow dispersion visualized in our study may be different
from the actual dispersion of infectious droplets with the expired
breath of newborn infants. There are no neonatal data on aerosol or
droplet size, and the potential viral content of these, making the
importance of dispersion distance unclear. However, aerosolization
studies from adult patients with respiratory infections found a pre-
dominance of pathogens in small particles of <5 µm.29 This is con-
sistent with the size of particles generated by our smoke generator.
With highly infectious agents such as SARS‐CoV‐2, precautions need
to be taken and mitigation strategies adopted until this is better
understood and more data becomes available as we learn more
about aerosol transmission in other settings.3
5 | CONCLUSIONS
In summary, our study demonstrates that during common neonatal
AGMPs, the risk of significant airflow dispersion is greater than
previously postulated but that it can be reduced with good mask
technique and the use of particle filters. Short‐term cuffed or tightly
fitting uncuffed ETTs should be considered on an individual basis
depending on the clinical circumstances of the infant and risk of
airway trauma, along with the risk of infectious respiratory viral
transmission. These measures, alongside correct use of appropriate
PPE, could minimize the risk of staff contamination from AGMPs
when caring for infants potentially infected with SARS‐CoV‐2 or
other respiratory viruses.
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